This collaboration fuels the expansion of a leading source of real-world clinical behavioral health data
Veradigm formerly Allscripts Healthcare Solutions,announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk’s $45 million series B financing round. The round was led by Veradigm, with participation from current investors including Heritas Capital, Health Catalyst Capital, Novartis (dRx Capital), and Northwell Holdings, the venture investment arm of Northwell Health, as well as other previous investors.
“Mental and behavioral health is a serious global health problem that has only increased during and post the COVID-19 pandemic”
Holmusk will leverage this investment to continue its rapid expansion of its flagship offering, the NeuroBlu Database—a leading source of real-world clinical data for the behavioral health industry.
Recommended AI: GoodFirms Unlocks the Best Task Management Software with Rich Features
Now that the financing has been completed, Veradigm and Holmusk intend to enter into a data partnership to bring cohorts of behavioral health and related de-identified patient data from Veradigm to the NeuroBlu Database, significantly adding to Holmusk’s real-world clinical data asset.
“Mental and behavioral health is a serious global health problem that has only increased during and post the COVID-19 pandemic,” said Rick Poulton, Veradigm Chief Executive Officer. “Holmusk has proven expertise to create the evidence needed to improve mental health. We are proud to equip the company with the resources needed to advance this important work.”
Recommended AI: Adelante Enhances Capabilities with Zendesk Setup Solution
“This investment will enable our team to continue its work in curating and enhancing data as we plan to build the world’s largest platform for behavioral health data,” said Nawal Roy, Holmusk Founder and CEO. “We remain laser-focused on this mission because we know that quality data leads to improved evidence, which leads to better health outcomes.”
“We feel fortunate to form a partnership with Veradigm, a company that shares our vision for the transformative power that data can have in health care,” said Michael Weintraub, Chair of the Holmusk Board. “Working collaboratively will help us to deepen our investment in the behavioral health space and make a broader impact.”
Recommended AI: Tacans Partners With Provenance Tags, Concordium Blockchain Based Anti-Counterfeiting Solution
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.